The efficacy and safety of rufinamide in drug-resistant epilepsy: A meta-analysis of double-blind, randomized, placebo controlled trials-Reference-Cited by-同舟云学术

The efficacy and safety of rufinamide in drug-resistant epilepsy: A meta-analysis of double-blind, randomized, placebo controlled trials

Published:2016-02 Issue: Volume:120 Page:104-110
ISSN:0920-1211
Container-title:Epilepsy Research
language:en
Short-container-title:Epilepsy Research

Author:

Xu Zhenghao,Zhao Huawei,Chen Zhong

Funder

National Natural Science Foundation of China

Research Program of Zhejiang Chinese Medical University

Program for Zhejiang Leading Team of S&T Innovation

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology

Reference27 articles.

1. Exposure to rufinamide and risks of CNS adverse events in drug-resistant epilepsy: a meta-analysis of randomized, placebo-controlled trials;Alsaad;Br. J. Clin. Pharmacol.,2014

2. Epilepsy: efficacy of epilepsy surgery: what are the questions today?;Berg;Nat. Rev. Neurol.,2011

3. Key factors in the discovery and development of new antiepileptic drugs;Bialer;Nat. Rev. Drug Discov.,2010

4. A randomized, double-blind, placebo-controlled, parallel-group study of rufinamide as adjunctive therapy for refractory partial-onset seizures;Biton;Epilepsia,2011

5. Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial;Brodie;Epilepsia,2009

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of traditional Chinese medicine for the treatment of epilepsy: A updated meta-analysis of randomized controlled trials;Epilepsy Research;2023-01

2. Rufinamide, a Triazole-Derived Antiepileptic Drug, Stimulates Ca2+-Activated K+ Currents While Inhibiting Voltage-Gated Na+ Currents;International Journal of Molecular Sciences;2022-11-08

Adjunctive Rufinamide in Children with Lennox-Gastaut Syndrome: A Literature Review

;Neuropsychiatric Disease and Treatment;2020-02

4. Risk of epilepsy in rheumatoid arthritis: a meta-analysis of population based studies and bioinformatics analysis;Therapeutic Advances in Chronic Disease;2020-01

5. Rufinamide efficacy and safety in children aged 1–4 years with Lennox–Gastaut syndrome;Brain and Development;2018-11